Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Rabbit Anti-Human RPA70 monoclonal antibody, clone U.92.0


View Antibody details

Rabbit Anti-Human RRM1 monoclonal antibody, clone TQ278


View Antibody details

Rabbit Anti-Human RSK Pan (phospho Ser221, Ser227, Ser218, Ser232) monoclonal antibody, clone 23I36M26


View Antibody details

Rabbit Anti-Human RSK1 (phospho Thr359, Ser363) monoclonal antibody, clone SN344


View Antibody details

Rabbit Anti-Human RSK1/RSK2/RSK3 monoclonal antibody, clone G.050.8


View Antibody details

Rabbit Anti-Human RSK3 (phospho Ser380) monoclonal antibody, clone D.947.6


View Antibody details

Rabbit Anti-Human RUNX1 monoclonal antibody, clone 4I3M7


View Antibody details

Rabbit Anti-Human S100A9 monoclonal antibody, clone KG107-9


View Antibody details

Rabbit Anti-Human S100B Monoclonal Antibody, Clone S12-2G0


View Antibody details

Rabbit Anti-Human S100P monoclonal antibody, clone KG06-19


View Antibody details